Page last updated: 2024-11-05

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Nasopharyngeal Neoplasms

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Nasopharyngeal Neoplasms in 1 studies

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.

Nasopharyngeal Neoplasms: Tumors or cancer of the NASOPHARYNX.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hong, B1
Lui, VW1
Hui, EP1
Lu, Y1
Leung, HS1
Wong, EY1
Cheng, SH1
Ng, MH1
Mills, GB1
Chan, AT1

Other Studies

1 other study available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Nasopharyngeal Neoplasms

ArticleYear
Reverse phase protein array identifies novel anti-invasion mechanisms of YC-1.
    Biochemical pharmacology, 2010, Mar-15, Volume: 79, Issue:6

    Topics: Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 1; Checkpo

2010